10 June 2025
EU Member States vote in favour of the first-ever IPI measures
1 min read
The EU is set to make the first use of its enforcement powers under the International Procurement Instrument.
The EU is set to make the first use of its enforcement powers under the International Procurement Instrument (IPI) and, after failing to persuade the Chinese government to open Chinese markets to EU producers, intends to severely curtail access of Chinese medical device makers to the EU. This will be a test case for the IPI, and it remains to be seen whether its use, alone or in conjunction with other instruments in the EU’s toolbox, will improve market access and lead to a more open EU-China trade relationship.
Our client alert below explores more.
Attachments:
Key contacts
->
News & insights
2 min
read
read
Briefings
Belgian Competition Authority Publishes Guidelines on Sustainability Agreements
7 April 2026
1 min
read
read
Briefings
Court of Justice of European Union Clarifies Scope of Officinal Formula Exemption Under EU Medicinal Product Law
25 March 2026
3 min
read
read
Briefings
UK CMA Concludes Veterinary Sector Market Investigation and Announces Major Reforms
24 March 2026
1 min
read
read
Briefings
European Commission publishes draft Industrial Accelerator Act: What to expect?
17 March 2026
1 min
read
read
Briefings
Belgian Competition Authority Investigates AutoScout24 Platform for Possible Abuse of Dominance
13 March 2026
2 min
read
read
Briefings
EU Pharmaceutical Package Moves Closer to Formal Adoption
6 March 2026
1 min
read
read
Briefings
EU General Court Annuls Anti-Circumvention Extension and rejects Commission’s Broad View of “Assembly Operations”
6 March 2026
